Shalini (Gupta) Dogra MD

Hematologic Oncology

Physician

8008 W Park DrMcLean, VA 22102
Phone+1 703-287-6720
Fax+1 703-287-6701

Dr. Dogra is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dogra's full profile Already have an account?

Education & Training

MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
MedStar Franklin Square Medical CenterResidency, Internal Medicine, 2001 - 2004
RNT Medical CollegeClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2007 - 2028
VA State Medical License 2008 - 2028
DC State Medical License 2004 - 2027
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

50 citations
Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
Aneeta Patel, Sissy M. Jhiang, Shalini Dogra, Richard Terrell, Patricia A Powers
Pediatric Research. 2002-11-01
17 citations
Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.
Rima Shah, Kevin P. Banks, Aneeta Patel, Shalini Dogra, Richard Terrell
The Journal of Clinical Endocrinology and Metabolism. 2002-09-01